Applied DNA Sciences, Inc. (NASDAQ:APDN) went down by -0.51% from its latest closing price when compared to the 1-year high value of $26.80 and move down -242.71%, while APDN stocks collected -18.88% of loss with the last five trading sessions. Press Release reported 12 hours ago that Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
Applied DNA Sciences, Inc. (NASDAQ:APDN) Worth an Investment?
Applied DNA Sciences, Inc. (NASDAQ: APDN) The 36 Months beta value for APDN stocks is at 0.98, while of the analysts out of 0 who provided ratings for Applied DNA Sciences, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $21.00 which is -$7.82 below current price. APDN currently has a short float of 5.21% and public float of 4.08M with average trading volume of 2.03M shares.
APDN Market Performance
APDN stocks went down by -18.88% for the week, with the monthly drop of -17.51% and a quarterly performance of 92.14%, while its annual performance rate touched -67.42%. The simple moving average for the period of the last 20 days is -22.95% for APDN stocks with the simple moving average of 16.52% for the last 200 days.
Analysts’ Opinion on Applied DNA Sciences, Inc. (NASDAQ:APDN)
Many brokerage firms have already submitted their reports for APDN stocks, with Maxim Group repeating the rating for APDN shares by setting it to “Buy”. The predicted price for APDN socks in the upcoming period according to Maxim Group is $6 based on the research report published on November 14, 2016.
Maxim Group, on the other hand, stated in their research note that they expect to see APDN stock at the price of $9, previously predicting the value of $13. The rating they have provided for APDN stocks is “Buy” according to the report published on May 13, 2016.
Maxim Group gave “Buy” rating to APDN stocks, setting the target price at $13 in the report published on October 8, 2015.
APDN Stocks 3.57% Far from 50 Day Moving Average
After a stumble in the market that brought APDN to its low price for the period of the last 52 weeks, Applied DNA Sciences, Inc. was unable to take a rebound, for now settling with -70.82% of loss for the given period.
The stock volatility was left at 11.74%, however, within the period of a single month, the volatility rate increased by 14.01%, while the shares sank at the distance of -16.54% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +80.18% upper at the present time.
In the course of the last 5 trading sessions, APDN went down by -18.88%, which changed the moving average for the period of 200 days to the total of -24.78% of losses for the stock in comparison to the 20-day moving average settled at $10.07. In addition, Applied DNA Sciences, Inc. saw 86.63% in overturn over the period of a single year with a tendency to cut further gains.
APDN Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Applied DNA Sciences, Inc. (APDN), starting from Montgomery William W, who bought 75,000 shares at the price of $5.25 back on Jun 09. After this action, Rushing now owns 175,000 shares of Applied DNA Sciences, Inc., valued at $393,750 with the latest closing price.
Montgomery William W, the 5% Owner of Applied DNA Sciences, Inc., bought 75,000 shares at the value of $5.24 during a trade that took place back on Nov 13, which means that Montgomery William W is holding 225,774 shares at the value of $393,000 based on the most recent closing price.
APDN Stock Fundamentals
The current profitability levels are settled at -169.31 for the present operating margin and +76.47 for gross margin. The net margin for Applied DNA Sciences, Inc. stands at -160.01. Total capital return value is set at -600.69, while invested capital returns managed to touch -566.39. Equity return holds the value -290.60%, with -120.10% for asset returns.
The value for Enterprise to Sales is 8.08 with debt to enterprise value settled at 0.17. The receivables turnover for Applied DNA Sciences, Inc. is 4.63 with the total asset turnover at the value of 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.96.